Sunday, June 19, 2022

'Queen' presents the kind of moral dilemmas found in Ibsen and Miller



      Queen, my first show of the new season, was a delight.    Playwright Madhuri Shekar hits all the right notes with her plot, character development and dialogue.  She turns a story about scientific research into an involving ethical discourse, presented within a well-paced one hour and 45 minutes, at the A.R.T./New York Mezzanine Theatre.

     Aneesha Kudtarkar seamlessly directs the excellent cast of four so I felt I was in the lab with these people, watching the drama unfold.  I liked the two main characters, Sanam Shah (Avanthika Srinivasan, right in photo) and Ariel Spiegel (Stephanie Janssen, left), Ph.D. candidates at the University of California Santa Cruz who have spent six years researching what has been killing an alarming number of honey bees.  They are ready to name pesticides produced by The Monsanto Company, an agrochemical manufacturer, as the culprit.  They’re at the final stage of their findings, which are scheduled to be published in a cover story for Nature, the most respected scientific journal in the country.  They will be able to write their own tickets after graduation.


     Until Sanam’s final data negates all of their work until then and they don’t have the result they had planned to present.   These two close friends, their professor who heads the project, Dr. Philip Hays (Ben Livingston), and Sanam’s new boyfriend, Arvind Patel (Keshav Moodliar), face the moral decision of what to do with this damning new information.  


    This is the kind of ethical dilemma I’ve always enjoyed in the plays of Ibsen and Miller.  As performed by these actors, the characters are never preachy or shrill.  They are believable people with a lot at stake.


     A subplot to the academic research story is the relationship between Sanam and Arvind, a Wall Street analyst she meets on a blind date arranged by her parents in India who want her to settle down with a successful Indian man.  They are clearly mismatched as she sits looking bored and he talks nonstop.  Finally, too distracted by her research findings, she says she’s going to the lab and, on impulse, invites him back to look at her calculations.  He’s eager, thinking that’s some kind of code for a sexual encounter but she’s only interested in his analyst’s brain because her results are no longer significant.


     “If they’re not significant, we have nothing,” she says. 


     He’s unconcerned, telling her, “Just oversample the old data.  They’re not gonna notice.” 


     That’s unacceptable to her so he gives it some thought.


     “So, if you’ve been getting significant results all this time, until, just now . . . sounds like . . . well, sounds like the threshold effect.”  


     He stands and points at her.


     “Aha!  You were biased.”


     Who wouldn’t be tempted to fudge a bit when the work of six years and all the expected glory it was to produce are threatened?  


     The production focuses completely on the characters and story.  Scenic designer Junghyun Georgia Lee wisely keeps the sets to a minimum, little more than lab tables forming a honeycomb that are reconfigured when needed.  Yuki Nakase Link’s lighting greatly enhances the atmosphere with its fluorescent vibe. 


     This inaugural production of the NAATCO National Partnership Project (NNPP) comes to New York City directly from Long Wharf Theatre in New Haven, CT.  NNPP establishes rigorous relationships with theatres around the country to ingrain strategies for the inclusion of Asian American theatre artists, technicians and administrators. 


     I hope Queen will move to one of the city’s major Off-Broadway theatres, with this cast.  It’s worthy of a step up. 

No comments: